The purpose of this study is to assess the safety and effectiveness of 3 doses of the investigational drug as compared to a placebo after 12 weeks of treatment in subjects with treatment-resistant hypertension.
Duration: Up to 6 months
Number of visits to CRC: 10 plus 2 phone call visits
If Qualified & you Participate you will Receive:
- Study-related care at no cost
- Highest standards of care overseen by a licensed Physician
- Compensation for time and travel
- Insurance is not required
Fill out the form on the right and see if you qualify for our clinical trial.